Spire Wealth Management Surface Oncology, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$2.65 - $5.08 $29,150 - $55,880	-11,000 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$4.73 - $7.9 $52,030 - $86,900	11,000 New	11,000 $53,000
Q2 2021 Jul 26, 2021	SELL	$6.45 - $9.09 $179,955 - $253,611	-27,900 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$7.25 - $13.82 $202,275 - $385,578	27,900 New	27,900 $220,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.